Jerrold B. Grossman - 30 Aug 2023 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Dr. Jerrold B. Grossman, by Brian Lenz as Attorney-in-fact
Issuer symbol
ADMA
Transactions as of
30 Aug 2023
Net transactions value
+$482,144
Form type
4
Filing time
30 Aug 2023, 16:58:14 UTC
Previous filing
08 Mar 2023
Next filing
28 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Purchase $482,144 +130,000 +41% $3.71 443,265 30 Aug 2023 Direct F1, F2
holding ADMA Common Stock 22,857 30 Aug 2023 See Footnote F3
holding ADMA Common Stock 31,381 30 Aug 2023 See Footnote F4
holding ADMA Common Stock 38,294 30 Aug 2023 See Footnote F5
holding ADMA Common Stock 175 30 Aug 2023 See Footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average price of purchases on August 30, 2023. The shares were purchased in multiple transactions ranging from $3.70 to $3.71, inclusive.
F2 Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023 that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date; and (ii) 417,450 shares of common stock owned by the reporting person.
F3 These shares are owned by Brookwood LLC ("Brookwood"). The reporting person is the managing member of Brookwood.
F4 These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee.
F5 These shares are owned by Genesis Foundation Inc. ("Genesis"). The reporting person is the President of Genesis.
F6 These shares are owned by the reporting person's wife.